![Sean Tucker](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Sean Tucker
Fondatore presso
VAXART, INC.
Patrimonio netto: 200 521 $ in data 31/07/2026
Profilo
Sean Tucker is the founder of Vaxart, Inc., founded in 2004.
Titles held at Vaxart, Inc. included Director & Vice President-Research from 2012 to 2013, and Chief Scientific Officer & Senior Vice President.
Former jobs include Principal at The Dow Chemical Co., Principal at Systemix, Inc., and Principal at Genteric, Inc. Education history includes undergraduate and doctorate degrees from the University of Washington, and a graduate degree from the University of California, Berkeley.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
VAXART, INC. 0,15% | 26/05/2026 | 371.336 ( 0,15% ) | 200 521 $ | 31/07/2026 |
Posizioni attive di Sean Tucker
| Società | Posizione | Inizio |
|---|---|---|
| VAXART, INC. | Fondatore | 01/03/2004 |
Precedenti posizioni note di Sean Tucker
| Società | Posizione | Fine |
|---|---|---|
| DOW CHEMICAL COMPANY (THE) | Corporate Officer/Principal | - |
Genteric, Inc.
 Genteric, Inc. Pharmaceuticals: MajorHealth Technology Develops revolutionary therapeutic protein delivery technology | Corporate Officer/Principal | - |
Systemix, Inc.
 Systemix, Inc. Medical/Nursing ServicesHealth Services Develops cell-based gene therapies for diseases | Corporate Officer/Principal | - |
Vaxart, Inc. /Old/
 Vaxart, Inc. /Old/ BiotechnologyHealth Technology Develops technology for oral vaccination against infectious agents | Fondatore | - |
Formazione di Sean Tucker
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
36
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
The Dow Chemical Co.
 The Dow Chemical Co. Chemicals: Major DiversifiedProcess Industries Manufactures specialty additives, modifiers and plastic polyethylene products | Process Industries |
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Develops cell-based gene therapies for diseases | Health Services |
Vaxart, Inc. /Old/
Vaxart, Inc. /Old/ BiotechnologyHealth Technology Develops technology for oral vaccination against infectious agents | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Genteric, Inc.
Genteric, Inc. Pharmaceuticals: MajorHealth Technology Develops revolutionary therapeutic protein delivery technology | Health Technology |
Vaxart, Inc.
 Vaxart, Inc. BiotechnologyHealth Technology Develops vaccines | Health Technology |
